These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 19881277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.
    Huang Z, Chen X, Fu H, Wen X, Ma C, Zhang J, Wu C, Huang Y, Pan X, Wu C.
    J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP.
    J Control Release; 1999 Aug 05; 60(2-3):279-86. PubMed ID: 10425333
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
    Zhu KJ, Jiang HL, Du XY, Wang J, Xu WX, Liu SF.
    J Microencapsul; 2001 Aug 05; 18(2):247-60. PubMed ID: 11253941
    [Abstract] [Full Text] [Related]

  • 12. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L, Cheng J, Chi Q, Qie J, Liu Y, Mei X.
    Chem Pharm Bull (Tokyo); 2006 Sep 05; 54(9):1259-65. PubMed ID: 16946531
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
    Rosa GD, Iommelli R, La Rotonda MI, Miro A, Quaglia F.
    J Control Release; 2000 Nov 03; 69(2):283-95. PubMed ID: 11064135
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
    Fu X, Ping Q, Gao Y.
    J Microencapsul; 2005 Nov 03; 22(7):705-14. PubMed ID: 16421082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.